Most metaplastic cancers are estrogen receptor (ER), progesterone receptor (PR) and Her2-neu negative [5-7] and tend to have a worse prognosis than other triple negative breast cancers [4,8-10] with fewer therapeutic options. This evidence concerns the gene ERBB2 and triple-negative breast carcinoma.